Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Articles
Agriculture
Alternative - Biofuels
Alternative - Cleantech
Base Metals
Battery Metals
Biotechnology / Pharmaceuticals
Clean Energy
Coal
Cobalt / Lithium / Manganese
Critical Metals
Cryptocurrency / Blockchain
Gold
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Oil & Gas - Exploration & Production
Oil & Gas - Services
PGM - Platinum Group Metals
Psychedelics
Regenerative Medicine
Renewable - Geothermal
Renewable - Solar
Renewable - Wind
Robotics
Silver
Special Situations
Technology
Uranium
Disclosures
Gain Therapeutics Inc.
GANX:NASDAQ
Streetwise Company Fact Sheet
2025/1/5 14:00:52
(GANX:NASDAQ)
Analyst coverage
Maxim Group
—
Jason McCarthy
Chardan Capital Markets
—
Keay Nakae
Oppenheimer & Co.
—
Jay Olson
ROTH Capital Partners
—
Dr. Boobalan Pachaiyappan
H.C. Wainwright & Co.
—
Dr. Ram Selvaraju
BTIG Research
—
Dr. Thomas Shrader
Streetwise Reports Articles
12/30/2024 - View Article
12/26/2024 - View Article
12/10/2024 - View Article
Streetwise - Gain Therapeutics Inc. Ownership Overview*
Gain Therapeutics Inc.
(GANX:NASDAQ)
*
Share Structure as of 12/10/2024